Mobile Phone Technology for Prevention of Mother-to-Child Transmission of HIV: Acceptability, Effectiveness, and Cost
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT01645865 |
Recruitment Status
:
Completed
First Posted
: July 20, 2012
Last Update Posted
: November 13, 2014
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment |
---|---|
HIV HIV Infections AIDS Antiretroviral Therapy | Behavioral: Control Behavioral: Intervention |
Study Type : | Observational |
Actual Enrollment : | 600 participants |
Observational Model: | Cohort |
Time Perspective: | Prospective |
Official Title: | Mobile Phone Technology for Prevention of Mother-to-Child Transmission of HIV: Acceptability, Effectiveness, and Cost |
Study Start Date : | May 2011 |
Actual Primary Completion Date : | April 2014 |
Actual Study Completion Date : | April 2014 |

Group/Cohort | Intervention/treatment |
---|---|
Control |
Behavioral: Control
Health facilities where PMTCT services are available in the traditional clinical setting with HIV testing and counseling, PMTCT support, and enrollment in care and treatment.
|
Intervention |
Behavioral: Intervention
In addition to the 'Standard of Care', HIV-infected pregnant women and male partners within the PMTCT program are engaged in multi-directional mobile communication for PMTCT promotion with health care providers.
|
- The proportion of women who successfully complete key PMTCT transition points from antenatal to six weeks postpartum. [ Time Frame: ~ 6 months ]
- Initiation of Infant prophylaxis, Facility delivery and receipt of results of 6 weeks early infant diagnosis by DNA PCR [ Time Frame: ~ 6 months ]
- Uptake ARV prophylaxis/ART during labor, delivery, and postpartum [ Time Frame: ~ 6 months ]
- Self-reported maternal adherence to ARV prophylaxis/ART during pregnancy [ Time Frame: ~ 4 months ]
- Time to initiation of ARV prophylaxis/ART uptake after initial identification of HIV seropositivity within ANC [ Time Frame: ~ 1 month ]

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | Child, Adult, Senior |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Sampling Method: | Non-Probability Sample |
Inclusion Criteria (female):
- HIV-positive pregnant women seeking ANC at a study site
- Up to 32 weeks gestation
- Own or have access to a mobile phone on which they can receive calls and SMS messages
Exclusion Criteria (female):
- HIV-positive pregnant women who have already initiated antiretroviral treatment
Inclusion Criteria (male):
- Referral by pregnant female partner

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01645865
Kenya | |
Elizabeth Glaser Pediatric AIDS Foundation | |
Nairobi, Kenya |
Principal Investigator: | John Ong'ech, MBChB, MMed, MPH | Elizabeth Glaser Pediatric AIDS Foundation, UON/KNH | |
Principal Investigator: | Seble Kassaye, MD, MS | Elizabeth Glaser Pediatric AIDS Foundation |
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: | Elizabeth Glaser Pediatric AIDS Foundation |
ClinicalTrials.gov Identifier: | NCT01645865 History of Changes |
Other Study ID Numbers: |
RPC441 |
First Posted: | July 20, 2012 Key Record Dates |
Last Update Posted: | November 13, 2014 |
Last Verified: | November 2014 |
Keywords provided by Elizabeth Glaser Pediatric AIDS Foundation:
HIV AIDS PMTCT Mobile Phone SMS |
Additional relevant MeSH terms:
HIV Infections Lentivirus Infections Retroviridae Infections RNA Virus Infections Virus Diseases |
Sexually Transmitted Diseases, Viral Sexually Transmitted Diseases Immunologic Deficiency Syndromes Immune System Diseases |